Literature DB >> 28087294

Bioactive metabolites of docosahexaenoic acid.

Ondrej Kuda1.   

Abstract

Docosahexaenoic acid (DHA) is an essential fatty acid that is recognized as a beneficial dietary constituent and as a source of the anti-inflammatory specialized proresolving mediators (SPM): resolvins, protectins and maresins. Apart from SPMs, other metabolites of DHA also exert potent biological effects. This article summarizes current knowledge on the metabolic pathways involved in generation of DHA metabolites. Over 70 biologically active metabolites have been described, but are often discussed separately within specific research areas. This review follows DHA metabolism and attempts to integrate the diverse DHA metabolites emphasizing those with identified biological effects. DHA metabolites could be divided into DHA-derived SPMs, DHA epoxides, electrophilic oxo-derivatives (EFOX) of DHA, neuroprostanes, ethanolamines, acylglycerols, docosahexaenoyl amides of amino acids or neurotransmitters, and branched DHA esters of hydroxy fatty acids. These bioactive metabolites have pleiotropic effects that include augmenting energy expenditure, stimulating lipid catabolism, modulating the immune response, helping to resolve inflammation, and promoting wound healing and tissue regeneration. As a result they have been shown to exert many beneficial actions: neuroprotection, anti-hypertension, anti-hyperalgesia, anti-arrhythmia, anti-tumorigenesis etc. Given the chemical structure of DHA, the number and geometry of double bonds, and the panel of enzymes metabolizing DHA, it is also likely that novel bioactive derivatives will be identified in the future.
Copyright © 2017 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  DHA; DHEA; FAHFA; N-acyl amides; Omega-3 PUFA; Specialized proresolving mediators

Mesh:

Substances:

Year:  2017        PMID: 28087294     DOI: 10.1016/j.biochi.2017.01.002

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  25 in total

1.  Effects of Low Phytanic Acid-Concentrated DHA on Activated Microglial Cells: Comparison with a Standard Phytanic Acid-Concentrated DHA.

Authors:  María Belén Ruiz-Roso; Elena Olivares-Álvaro; José Carlos Quintela; Sandra Ballesteros; Juan F Espinosa-Parrilla; Baltasar Ruiz-Roso; Vicente Lahera; Natalia de Las Heras; Beatriz Martín-Fernández
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

Review 2.  Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome.

Authors:  C Ronald Kahn; Guoxiao Wang; Kevin Y Lee
Journal:  J Clin Invest       Date:  2019-10-01       Impact factor: 14.808

3.  Acute injection of a DHA triglyceride emulsion after hypoxic-ischemic brain injury in mice increases both DHA and EPA levels in blood and brain.

Authors:  Denny Joseph Manual Kollareth; Richard J Deckelbaum; Zequn Liu; Rajasekhar Ramakrishnan; Charlotte Jouvene; Charles N Serhan; Vadim S Ten; Hylde Zirpoli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-25       Impact factor: 4.006

4.  Metabolomic profiling of the excretory-secretory products of hookworm and whipworm.

Authors:  Phurpa Wangchuk; Konstantinos Kouremenos; Ramon M Eichenberger; Mark Pearson; Atik Susianto; David S Wishart; Malcolm J McConville; Alex Loukas
Journal:  Metabolomics       Date:  2019-06-28       Impact factor: 4.290

5.  Post-stroke DHA Treatment Protects Against Acute Ischemic Brain Injury by Skewing Macrophage Polarity Toward the M2 Phenotype.

Authors:  Wei Cai; Sanxin Liu; Mengyan Hu; Xiaobo Sun; Wei Qiu; Songguo Zheng; Xiaoming Hu; Zhengqi Lu
Journal:  Transl Stroke Res       Date:  2018-09-10       Impact factor: 6.829

6.  Specialized Pro-Resolving Lipid Mediators Regulate Ozone-Induced Pulmonary and Systemic Inflammation.

Authors:  Brita Kilburg-Basnyat; Sky W Reece; Miranda J Crouch; Bin Luo; Andria D Boone; Michael Yaeger; Myles Hodge; Christine Psaltis; Johanna L Hannan; Jonathan Manke; Michael L Armstrong; Nichole Reisdorph; Robert M Tighe; Saame Raza Shaikh; Kymberly M Gowdy
Journal:  Toxicol Sci       Date:  2018-06-01       Impact factor: 4.849

Review 7.  Omega-3 Index and Anti-Arrhythmic Potential of Omega-3 PUFAs.

Authors:  Narcis Tribulova; Barbara Szeiffova Bacova; Tamara Egan Benova; Vladimir Knezl; Miroslav Barancik; Jan Slezak
Journal:  Nutrients       Date:  2017-10-30       Impact factor: 5.717

8.  DHA 12-LOX-derived oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway.

Authors:  Adriana Yamaguchi; Livia Stanger; Cody J Freedman; Melissa Standley; Timothy Hoang; Reheman Adili; Wan-Chen Tsai; Christopher van Hoorebeke; Theodore R Holman; Michael Holinstat
Journal:  J Thromb Haemost       Date:  2020-12-16       Impact factor: 5.824

9.  Effect of the Expression of ELOVL5 and IGFBP6 Genes on the Metastatic Potential of Breast Cancer Cells.

Authors:  Sergey Nikulin; Galina Zakharova; Andrey Poloznikov; Maria Raigorodskaya; Daniel Wicklein; Udo Schumacher; Stepan Nersisyan; Jonas Bergquist; Georgy Bakalkin; Lidiia Astakhova; Alexander Tonevitsky
Journal:  Front Genet       Date:  2021-06-02       Impact factor: 4.599

Review 10.  Maternal Supply of Both Arachidonic and Docosahexaenoic Acids Is Required for Optimal Neurodevelopment.

Authors:  Sanjay Basak; Rahul Mallick; Antara Banerjee; Surajit Pathak; Asim K Duttaroy
Journal:  Nutrients       Date:  2021-06-16       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.